[1]麦尔耶姆·瓦热斯 罗心平 周鹏.糖尿病与心力衰竭:2型糖尿病是心力衰竭的独立危险因素?[J].心血管病学进展,2020,(7):681-683.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.002]
 Maieryemu·Waresi,LUO Xinping,ZHOU Peng.Diabetes and Heart Failure: Is Type 2 Diabetes an Independent Risk Factor for Heart Failure?[J].Advances in Cardiovascular Diseases,2020,(7):681-683.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.002]
点击复制

糖尿病与心力衰竭:2型糖尿病是心力衰竭的独立危险因素?()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年7期
页码:
681-683
栏目:
出版日期:
2020-07-25

文章信息/Info

Title:
Diabetes and Heart Failure: Is Type 2 Diabetes an Independent Risk Factor for Heart Failure?
作者:
麦尔耶姆·瓦热斯 罗心平 周鹏
复旦大学附属华山医院心内科,上海 200040
Author(s):
Maieryemu·Waresi LUO Xinping ZHOU Peng
(Department of Cardiology, Huashan Hospital, Fudan University, Shanghai 200040China)
关键词:
糖尿病心力衰竭风险糖化血红蛋白
Keywords:
Diabetes Heart failure Risk HbA1c
分类号:
R541
DOI:
10.16806/j.cnki.issn.1004-3934.2020.07.002
文献标志码:
A
摘要:
糖尿病和心力衰竭是现代社会的常见病,尤其在人口老龄化严重的中国更是如此。大量研究已证实,糖尿病与心血管疾病有关,但它与心力衰竭的关系一直无法确认。糖尿病与心力衰竭之间的关系会影响临床诊疗决策,提示疾病的预后。如今,越来越多的研究关注到糖尿病患者心力衰竭的发生风险。现综述近几年来聚焦于“糖尿病与心力衰竭”之间关系的研究,旨在为糖尿病和心力衰竭的诊疗提供一些参考。
Abstract:
Diabetes and heart failure are common diseases in modern society, especially in China, where the population is severely aging. Numerous studies have confirmed that diabetes is related to cardiovascular disease, but it’s relationship with heart failure has not been confirmed yet. The relationship between diabetes and heart failure will influence clinical decisions, suggesting the prognosis of the disease. Nowadays, more and more studies focus on the risk of heart failure in patients with diabetes. This article mainly reviews the research focusing on the relationship between "diabetes and heart failure" in recent years, and aims to provide some references for the diagnosis and treatment of diabetes and heart failure

参考文献/References:

[1]陈志华,张梅,李镒冲,等. 我国成年人血压水平与心脑血管疾病行为危险因素及其聚集关系分析[J]. 中华流行病学杂志 ,2018,39(5):640-645.

[2]Hao G,Wang X,Che Z,et al.Prevalence of heart failure and left ventricular dysfunction in China:the China Hypertension Survey, 2012–2015 [J].Eur J Heart Fail,2019,21(11):1329-1337.

[3]Centers for Disease Control and Prevention. National diabetes statistics report[R].2014.https://www.cdc.gov/diabetes/pdfs/data/2014-report-estimates-of-diabetes-and-its-burden-in-the-united-states.pdf. Accessed January 18, 2017.

[4]Benjamin EJ,Virani SS,Callaway CW,et al.Heart disease and stroke statistics—2018 update: a report from the American Heart Association[J] .Circulation, 2018,137(12):e67-e492.

[5]Thrainsdottir IS,Aspelund T,Thorgeirsson G,et al.The association between glucose abnormalities and heart failure in the population-based Reykjavik study[J]. Diabetes Care,2005,28(3):612-616.

[6]Kannel WB,McGee DL.Diabetes and cardiovascular disease:The Framingham study[J].JAMA,1979,241(19):2035-2038.

[7] Rubler S,Dlugash J,Yuceoglu YZ,et al.New type of cardiomyopathy associated with diabetic glomerulosclerosis[J].Am J Cardiol,1972,30(6):595-602.

[8] Marwick TH,Ritchie R,Shaw JE,et al.Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy [J].J Am Coll Cardiol,2018,71(3):339-351.

[9]Levelt E,Mahmod M,Piechnik SK,et al.Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes[J].Diabetes, 2016,65(1):44-52.

[10]Iribarren C,Karter AJ,Go AS,et al.Glycemic control and heart failure among adult patients with diabetes[J].Circulation,2001,103(22):2668-2673.

[11]Huynh K,Bernardo BC,Mcmullen JR,et al.Diabetic cardiomyopathy:mechanisms and new treatment strategies targeting antioxidant signaling pathways[J]. Pharmacol Ther,2014,142(3):375-415.

[12]Huynh K,Kiriazis H,Du XJ,et al.Coenzyme Q10 attenuates diastolic dysfunction,cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes[J].Diabetologia,2012,55(5):1544-1553.

[13]Lebeche D,Davidoff AJ,Hajjar RJ.Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy[J].Nat Clin Pract Cardiovasc Med,2008,5(11):715-724.

[14]Bugger H,Abel ED.Molecular mechanisms of diabetic cardiomyopathy[J]. Diabetologia ,2014,57(4):660-671.

[15]Basta G,del Turco S,De Caterina R. Advanced glycation endproducts: implications for accelerated atherosclerosis in diabetes[J].Recenti Prog Med,2004,95(2):67-80.

[16]Huynh K, Kiriazis H ,Du XJ,et al. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice[J]. Free Radical Biol Med,2013,60(7):307-317.

[17]Yap J,Tay WT,Teng TK,et al. Association of diabetes mellitus on cardiac remodeling,quality of life,and clinical outcomes in heart failure with reduced and preserved ejection fraction[J]. J Am Heart Assoc,2019,8(17): e013114.

[18]Bertoni AG,Hundley WG, Massing MW ,et al.Heart failure prevalence,incidence, and mortality in the elderly with diabetes [J].Diabetes Care,2004,27(3):699-703.

[19]Dauriz M,Mantovani A,Bonapace S,et al.Prognostic impact of diabetes on long-term survival outcomes in patients with heart failure:a meta-analysis[J]. Diabetes Care ,2017,40(11):1597-1605.

[20]程宏基,黄裕立,黄伟俊,等.入院血糖水平不同的分组方法对急性心力衰竭患者远期预后影响的比较[J].心血管病学进展,2019,(9):1323-1329.

相似文献/References:

[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
 DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(7):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
 LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(7):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
 ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(7):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]张若愚,综述,殷跃辉,等.2型糖尿病及其药物对心房颤动的影响[J].心血管病学进展,2016,(4):337.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.003]
 ZHANG Ruoyu,YIN Yuehui.Effect of Type 2 Diabetes Mellitus and Diabetic Drugs on Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(7):337.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.003]
[5]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
 LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(7):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[6]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
 KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(7):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[7]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
 SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(7):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[8]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
 HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[9]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
 XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(7):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[10]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
 GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(7):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[11]菲尔凯提·玉山江李昊穆叶赛·尼加提.射血分数保留性心力衰竭合并糖尿病的研究进展[J].心血管病学进展,2020,(4):373.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.011]
 FEIERKAITI·Yushanjiang,LIHao,MUYESAI.Nijiati.Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2020,(7):373.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.011]

更新日期/Last Update: 2020-10-09